nodes	percent_of_prediction	percent_of_DWPC	metapath
Phylloquinone—BGLAP—skull—epilepsy syndrome	0.0776	0.353	CbGeAlD
Phylloquinone—BGLAP—forelimb—epilepsy syndrome	0.0747	0.34	CbGeAlD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—BRD2—epilepsy syndrome	0.0274	0.115	CbGpPWpGaD
Phylloquinone—Vitamin E—PRKCB—epilepsy syndrome	0.0177	0.597	CrCbGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—ASCL1—epilepsy syndrome	0.0156	0.0658	CbGpPWpGaD
Phylloquinone—Atrophy—Vigabatrin—epilepsy syndrome	0.0155	0.0302	CcSEcCtD
Phylloquinone—GGCX—telencephalon—epilepsy syndrome	0.0152	0.0692	CbGeAlD
Phylloquinone—Vitamin E—HMOX1—epilepsy syndrome	0.012	0.403	CrCbGaD
Phylloquinone—Injection site reaction—Amobarbital—epilepsy syndrome	0.00995	0.0194	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUND—epilepsy syndrome	0.00975	0.041	CbGpPWpGaD
Phylloquinone—BGLAP—head—epilepsy syndrome	0.0097	0.0442	CbGeAlD
Phylloquinone—Necrosis—Phenobarbital—epilepsy syndrome	0.00957	0.0187	CcSEcCtD
Phylloquinone—GGCX—head—epilepsy syndrome	0.00947	0.0431	CbGeAlD
Phylloquinone—GGCX—nervous system—epilepsy syndrome	0.00897	0.0409	CbGeAlD
Phylloquinone—GGCX—central nervous system—epilepsy syndrome	0.00864	0.0393	CbGeAlD
Phylloquinone—Injection site pain—Lacosamide—epilepsy syndrome	0.00848	0.0165	CcSEcCtD
Phylloquinone—GGCX—cerebellum—epilepsy syndrome	0.00845	0.0385	CbGeAlD
Phylloquinone—Injection site reaction—Phenobarbital—epilepsy syndrome	0.00747	0.0146	CcSEcCtD
Phylloquinone—Injection site pain—Acetazolamide—epilepsy syndrome	0.00734	0.0143	CcSEcCtD
Phylloquinone—Cyanosis—Fosphenytoin—epilepsy syndrome	0.00733	0.0143	CcSEcCtD
Phylloquinone—Cyanosis—Diazepam—epilepsy syndrome	0.00703	0.0137	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—ITGA2—epilepsy syndrome	0.00696	0.0293	CbGpPWpGaD
Phylloquinone—GGCX—brain—epilepsy syndrome	0.00686	0.0312	CbGeAlD
Phylloquinone—Injection site pain—Propofol—epilepsy syndrome	0.00681	0.0133	CcSEcCtD
Phylloquinone—Injection site pain—Midazolam—epilepsy syndrome	0.00667	0.013	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUNB—epilepsy syndrome	0.00663	0.0279	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—CDH2—epilepsy syndrome	0.00642	0.027	CbGpPWpGaD
Phylloquinone—Cyanosis—Phenytoin—epilepsy syndrome	0.00638	0.0124	CcSEcCtD
Phylloquinone—Injection site pain—Fosphenytoin—epilepsy syndrome	0.00635	0.0124	CcSEcCtD
Phylloquinone—Necrosis—Felbamate—epilepsy syndrome	0.00614	0.012	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—epilepsy syndrome	0.00609	0.0256	CbGpPWpGaD
Phylloquinone—Cyanosis—Carbamazepine—epilepsy syndrome	0.00609	0.0119	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—PIGN—epilepsy syndrome	0.00584	0.0246	CbGpPWpGaD
Phylloquinone—GGCX—Post-translational protein modification—PIGT—epilepsy syndrome	0.00584	0.0246	CbGpPWpGaD
Phylloquinone—Necrosis—Phenytoin—epilepsy syndrome	0.00575	0.0112	CcSEcCtD
Phylloquinone—Injection site pain—Phenytoin—epilepsy syndrome	0.00553	0.0108	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—HMOX1—epilepsy syndrome	0.0055	0.0231	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—PTK2B—epilepsy syndrome	0.00546	0.023	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—DUSP6—epilepsy syndrome	0.00527	0.0222	CbGpPWpGaD
Phylloquinone—Injection site reaction—Fosphenytoin—epilepsy syndrome	0.00516	0.0101	CcSEcCtD
Phylloquinone—Injection site reaction—Diazepam—epilepsy syndrome	0.00495	0.00965	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—MAPK10—epilepsy syndrome	0.00493	0.0207	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—SOCS3—epilepsy syndrome	0.00491	0.0207	CbGpPWpGaD
Phylloquinone—Phlebitis—Propofol—epilepsy syndrome	0.00469	0.00914	CcSEcCtD
Phylloquinone—Inflammation—Clonazepam—epilepsy syndrome	0.00469	0.00913	CcSEcCtD
Phylloquinone—Inflammation—Phenytoin—epilepsy syndrome	0.00465	0.00907	CcSEcCtD
Phylloquinone—Phlebitis—Midazolam—epilepsy syndrome	0.00459	0.00894	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Lamotrigine—epilepsy syndrome	0.00458	0.00893	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—PLAUR—epilepsy syndrome	0.0045	0.0189	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Acetazolamide—epilepsy syndrome	0.00449	0.00876	CcSEcCtD
Phylloquinone—Injection site reaction—Phenytoin—epilepsy syndrome	0.00449	0.00875	CcSEcCtD
Phylloquinone—Swelling—Midazolam—epilepsy syndrome	0.00448	0.00873	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—FYN—epilepsy syndrome	0.00436	0.0183	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—epilepsy syndrome	0.00427	0.018	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—HES1—epilepsy syndrome	0.00425	0.0179	CbGpPWpGaD
Phylloquinone—Cyanosis—Pregabalin—epilepsy syndrome	0.00423	0.00824	CcSEcCtD
Phylloquinone—Necrosis—Valproic Acid—epilepsy syndrome	0.00422	0.00822	CcSEcCtD
Phylloquinone—Phlebitis—Diazepam—epilepsy syndrome	0.00419	0.00818	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Propofol—epilepsy syndrome	0.00417	0.00813	CcSEcCtD
Phylloquinone—Swelling—Diazepam—epilepsy syndrome	0.0041	0.00798	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Midazolam—epilepsy syndrome	0.00408	0.00796	CcSEcCtD
Phylloquinone—Injection site pain—Valproic Acid—epilepsy syndrome	0.00405	0.0079	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—NEU1—epilepsy syndrome	0.00405	0.017	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Fosphenytoin—epilepsy syndrome	0.00389	0.00758	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—PIGA—epilepsy syndrome	0.00377	0.0158	CbGpPWpGaD
Phylloquinone—Swelling—Clonazepam—epilepsy syndrome	0.00374	0.00729	CcSEcCtD
Phylloquinone—Injection site pain—Pregabalin—epilepsy syndrome	0.00366	0.00714	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—VDAC1—epilepsy syndrome	0.00366	0.0154	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Felbamate—epilepsy syndrome	0.00361	0.00704	CcSEcCtD
Phylloquinone—Sweating—Clobazam—epilepsy syndrome	0.0036	0.00702	CcSEcCtD
Phylloquinone—Swelling—Carbamazepine—epilepsy syndrome	0.00355	0.00691	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—epilepsy syndrome	0.00354	0.0149	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—IL6ST—epilepsy syndrome	0.00345	0.0145	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—KDR—epilepsy syndrome	0.00341	0.0143	CbGpPWpGaD
Phylloquinone—Sweating increased—Propofol—epilepsy syndrome	0.0034	0.00663	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Phenytoin—epilepsy syndrome	0.00339	0.0066	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—SIRT1—epilepsy syndrome	0.00336	0.0141	CbGpPWpGaD
Phylloquinone—Immune system disorder—Rufinamide—epilepsy syndrome	0.00334	0.00652	CcSEcCtD
Phylloquinone—Hypotension—Amobarbital—epilepsy syndrome	0.00334	0.0065	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Pregabalin—epilepsy syndrome	0.00329	0.00641	CcSEcCtD
Phylloquinone—Injection site reaction—Valproic Acid—epilepsy syndrome	0.00329	0.00641	CcSEcCtD
Phylloquinone—Erythema—Phenobarbital—epilepsy syndrome	0.00328	0.0064	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—PLAU—epilepsy syndrome	0.00316	0.0133	CbGpPWpGaD
Phylloquinone—Immune system disorder—Lacosamide—epilepsy syndrome	0.00314	0.00612	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—MEF2C—epilepsy syndrome	0.00314	0.0132	CbGpPWpGaD
Phylloquinone—GGCX—Post-translational protein modification—ST3GAL3—epilepsy syndrome	0.00313	0.0132	CbGpPWpGaD
Phylloquinone—Erythema—Lacosamide—epilepsy syndrome	0.00303	0.0059	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—ST3GAL5—epilepsy syndrome	0.00301	0.0127	CbGpPWpGaD
Phylloquinone—Injection site reaction—Pregabalin—epilepsy syndrome	0.00297	0.0058	CcSEcCtD
Phylloquinone—Flushing—Acetazolamide—epilepsy syndrome	0.00279	0.00544	CcSEcCtD
Phylloquinone—Sweating—Fosphenytoin—epilepsy syndrome	0.00278	0.00542	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—PIGN—epilepsy syndrome	0.00277	0.0117	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—PIGT—epilepsy syndrome	0.00277	0.0117	CbGpPWpGaD
Phylloquinone—Sweating increased—Oxcarbazepine—epilepsy syndrome	0.00274	0.00535	CcSEcCtD
Phylloquinone—Swelling—Valproic Acid—epilepsy syndrome	0.00272	0.00531	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—FOS—epilepsy syndrome	0.00268	0.0113	CbGpPWpGaD
Phylloquinone—Sweating—Diazepam—epilepsy syndrome	0.00267	0.0052	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—BCL2—epilepsy syndrome	0.00265	0.0111	CbGpPWpGaD
Phylloquinone—Sweating increased—Carbamazepine—epilepsy syndrome	0.00263	0.00513	CcSEcCtD
Phylloquinone—Hypersensitivity—Amobarbital—epilepsy syndrome	0.00263	0.00513	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—epilepsy syndrome	0.0026	0.011	CbGpPWpGaD
Phylloquinone—Flushing—Propofol—epilepsy syndrome	0.00259	0.00505	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—RELA—epilepsy syndrome	0.00259	0.0109	CbGpPWpGaD
Phylloquinone—Sweating—Felbamate—epilepsy syndrome	0.00258	0.00504	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—GOSR2—epilepsy syndrome	0.00254	0.0107	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—epilepsy syndrome	0.00253	0.0107	CbGpPWpGaD
Phylloquinone—Sweating—Zonisamide—epilepsy syndrome	0.00253	0.00493	CcSEcCtD
Phylloquinone—Phlebitis—Pregabalin—epilepsy syndrome	0.00252	0.00491	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—NR3C1—epilepsy syndrome	0.00251	0.0105	CbGpPWpGaD
Phylloquinone—Hypotension—Phenobarbital—epilepsy syndrome	0.0025	0.00488	CcSEcCtD
Phylloquinone—Immune system disorder—Midazolam—epilepsy syndrome	0.00247	0.00481	CcSEcCtD
Phylloquinone—Immune system disorder—Levetiracetam—epilepsy syndrome	0.00244	0.00475	CcSEcCtD
Phylloquinone—Erythema—Propofol—epilepsy syndrome	0.00243	0.00474	CcSEcCtD
Phylloquinone—Sweating—Phenytoin—epilepsy syndrome	0.00242	0.00472	CcSEcCtD
Phylloquinone—Hyperhidrosis—Lacosamide—epilepsy syndrome	0.00239	0.00466	CcSEcCtD
Phylloquinone—Erythema—Midazolam—epilepsy syndrome	0.00238	0.00464	CcSEcCtD
Phylloquinone—Dizziness—Amobarbital—epilepsy syndrome	0.00236	0.0046	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ERN1—epilepsy syndrome	0.00236	0.00992	CbGpPWpGaD
Phylloquinone—Hyperhidrosis—Clobazam—epilepsy syndrome	0.00232	0.00452	CcSEcCtD
Phylloquinone—Phlebitis—Gabapentin—epilepsy syndrome	0.00231	0.00451	CcSEcCtD
Phylloquinone—Pain—Phenobarbital—epilepsy syndrome	0.00229	0.00447	CcSEcCtD
Phylloquinone—Dizziness—Primidone—epilepsy syndrome	0.00227	0.00443	CcSEcCtD
Phylloquinone—Swelling—Gabapentin—epilepsy syndrome	0.00226	0.0044	CcSEcCtD
Phylloquinone—Flushing—Felbamate—epilepsy syndrome	0.00225	0.00438	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Pregabalin—epilepsy syndrome	0.00224	0.00437	CcSEcCtD
Phylloquinone—Hypotension—Clobazam—epilepsy syndrome	0.00224	0.00437	CcSEcCtD
Phylloquinone—Sweating—Lamotrigine—epilepsy syndrome	0.00223	0.00435	CcSEcCtD
Phylloquinone—Erythema—Diazepam—epilepsy syndrome	0.00218	0.00424	CcSEcCtD
Phylloquinone—Immune system disorder—Zonisamide—epilepsy syndrome	0.00214	0.00417	CcSEcCtD
Phylloquinone—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.00214	0.00417	CcSEcCtD
Phylloquinone—Flushing—Clonazepam—epilepsy syndrome	0.00212	0.00413	CcSEcCtD
Phylloquinone—Flushing—Oxcarbazepine—epilepsy syndrome	0.00209	0.00408	CcSEcCtD
Phylloquinone—Immune system disorder—Clonazepam—epilepsy syndrome	0.00206	0.00402	CcSEcCtD
Phylloquinone—Immune system disorder—Phenytoin—epilepsy syndrome	0.00205	0.00399	CcSEcCtD
Phylloquinone—Immune system disorder—Oxcarbazepine—epilepsy syndrome	0.00204	0.00397	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—SRC—epilepsy syndrome	0.00203	0.00855	CbGpPWpGaD
Phylloquinone—Sweating increased—Valproic Acid—epilepsy syndrome	0.00202	0.00394	CcSEcCtD
Phylloquinone—Flushing—Carbamazepine—epilepsy syndrome	0.00201	0.00392	CcSEcCtD
Phylloquinone—Anaphylactic shock—Propofol—epilepsy syndrome	0.00198	0.00387	CcSEcCtD
Phylloquinone—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.00197	0.00385	CcSEcCtD
Phylloquinone—Immune system disorder—Carbamazepine—epilepsy syndrome	0.00195	0.00381	CcSEcCtD
Phylloquinone—Phlebitis—Topiramate—epilepsy syndrome	0.00194	0.00379	CcSEcCtD
Phylloquinone—Anaphylactic shock—Midazolam—epilepsy syndrome	0.00194	0.00379	CcSEcCtD
Phylloquinone—Flushing—Lamotrigine—epilepsy syndrome	0.00194	0.00378	CcSEcCtD
Phylloquinone—Hypersensitivity—Rufinamide—epilepsy syndrome	0.00194	0.00378	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—JUN—epilepsy syndrome	0.00192	0.00809	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—NEU1—epilepsy syndrome	0.00192	0.00809	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.00192	0.00809	CbGpPWpGaD
Phylloquinone—Hyperhidrosis—Propofol—epilepsy syndrome	0.00192	0.00374	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	0.00192	0.00807	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	0.00192	0.00806	CbGpPWpGaD
Phylloquinone—Erythema—Carbamazepine—epilepsy syndrome	0.00188	0.00367	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—MMP9—epilepsy syndrome	0.00187	0.00788	CbGpPWpGaD
Phylloquinone—Hypotension—Propofol—epilepsy syndrome	0.00185	0.00362	CcSEcCtD
Phylloquinone—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.00185	0.00361	CcSEcCtD
Phylloquinone—Erythema—Lamotrigine—epilepsy syndrome	0.00182	0.00355	CcSEcCtD
Phylloquinone—Hypersensitivity—Lacosamide—epilepsy syndrome	0.00182	0.00355	CcSEcCtD
Phylloquinone—Hypotension—Midazolam—epilepsy syndrome	0.00181	0.00354	CcSEcCtD
Phylloquinone—Hyperhidrosis—Fosphenytoin—epilepsy syndrome	0.00179	0.00349	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—PIGA—epilepsy syndrome	0.00179	0.00752	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—TPP1—epilepsy syndrome	0.00179	0.00752	CbGpPWpGaD
Phylloquinone—Anaphylactic shock—Diazepam—epilepsy syndrome	0.00178	0.00346	CcSEcCtD
Phylloquinone—Sweating—Valproic Acid—epilepsy syndrome	0.00177	0.00346	CcSEcCtD
Phylloquinone—Dizziness—Phenobarbital—epilepsy syndrome	0.00177	0.00345	CcSEcCtD
Phylloquinone—Dyspnoea—Propofol—epilepsy syndrome	0.00177	0.00345	CcSEcCtD
Phylloquinone—Dizziness—Rufinamide—epilepsy syndrome	0.00174	0.00339	CcSEcCtD
Phylloquinone—Dyspnoea—Midazolam—epilepsy syndrome	0.00173	0.00337	CcSEcCtD
Phylloquinone—Hypotension—Fosphenytoin—epilepsy syndrome	0.00173	0.00337	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—SRC—epilepsy syndrome	0.00173	0.00726	CbGpPWpGaD
Phylloquinone—Anaphylactic shock—Felbamate—epilepsy syndrome	0.00172	0.00335	CcSEcCtD
Phylloquinone—Hyperhidrosis—Diazepam—epilepsy syndrome	0.00172	0.00335	CcSEcCtD
Phylloquinone—Pain—Propofol—epilepsy syndrome	0.0017	0.00331	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.00168	0.00707	CbGpPWpGaD
Phylloquinone—Sweating increased—Gabapentin—epilepsy syndrome	0.00168	0.00327	CcSEcCtD
Phylloquinone—Hyperhidrosis—Felbamate—epilepsy syndrome	0.00166	0.00324	CcSEcCtD
Phylloquinone—Pain—Midazolam—epilepsy syndrome	0.00166	0.00324	CcSEcCtD
Phylloquinone—Hypotension—Diazepam—epilepsy syndrome	0.00166	0.00323	CcSEcCtD
Phylloquinone—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.00165	0.00322	CcSEcCtD
Phylloquinone—Pain—Levetiracetam—epilepsy syndrome	0.00164	0.0032	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—JUN—epilepsy syndrome	0.00164	0.00689	CbGpPWpGaD
Phylloquinone—Dizziness—Lacosamide—epilepsy syndrome	0.00163	0.00318	CcSEcCtD
Phylloquinone—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.00163	0.00317	CcSEcCtD
Phylloquinone—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.00162	0.00316	CcSEcCtD
Phylloquinone—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.00161	0.00314	CcSEcCtD
Phylloquinone—Hypotension—Felbamate—epilepsy syndrome	0.00161	0.00313	CcSEcCtD
Phylloquinone—Sweating—Pregabalin—epilepsy syndrome	0.0016	0.00313	CcSEcCtD
Phylloquinone—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.0016	0.00312	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ADD1—epilepsy syndrome	0.00159	0.0067	CbGpPWpGaD
Phylloquinone—Dizziness—Clobazam—epilepsy syndrome	0.00159	0.00309	CcSEcCtD
Phylloquinone—Dyspnoea—Diazepam—epilepsy syndrome	0.00158	0.00309	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	0.00157	0.00661	CbGpPWpGaD
Phylloquinone—Hypotension—Zonisamide—epilepsy syndrome	0.00157	0.00306	CcSEcCtD
Phylloquinone—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.00156	0.00304	CcSEcCtD
Phylloquinone—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.00155	0.00302	CcSEcCtD
Phylloquinone—Pain—Vigabatrin—epilepsy syndrome	0.00154	0.00301	CcSEcCtD
Phylloquinone—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.00154	0.003	CcSEcCtD
Phylloquinone—Dyspnoea—Felbamate—epilepsy syndrome	0.00153	0.00299	CcSEcCtD
Phylloquinone—Pain—Diazepam—epilepsy syndrome	0.00152	0.00296	CcSEcCtD
Phylloquinone—Hypotension—Clonazepam—epilepsy syndrome	0.00152	0.00295	CcSEcCtD
Phylloquinone—Hypotension—Phenytoin—epilepsy syndrome	0.00151	0.00293	CcSEcCtD
Phylloquinone—Immune system disorder—Valproic Acid—epilepsy syndrome	0.0015	0.00293	CcSEcCtD
Phylloquinone—Dyspnoea—Zonisamide—epilepsy syndrome	0.0015	0.00292	CcSEcCtD
Phylloquinone—Hypotension—Oxcarbazepine—epilepsy syndrome	0.0015	0.00292	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.00149	0.00626	CbGpPWpGaD
Phylloquinone—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.00149	0.0029	CcSEcCtD
Phylloquinone—Sweating—Gabapentin—epilepsy syndrome	0.00147	0.00287	CcSEcCtD
Phylloquinone—Pain—Felbamate—epilepsy syndrome	0.00147	0.00287	CcSEcCtD
Phylloquinone—Dyspnoea—Clonazepam—epilepsy syndrome	0.00145	0.00282	CcSEcCtD
Phylloquinone—Hypotension—Carbamazepine—epilepsy syndrome	0.00144	0.0028	CcSEcCtD
Phylloquinone—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.00144	0.0028	CcSEcCtD
Phylloquinone—Dyspnoea—Phenytoin—epilepsy syndrome	0.00144	0.0028	CcSEcCtD
Phylloquinone—Hypersensitivity—Midazolam—epilepsy syndrome	0.00143	0.00279	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.00143	0.00601	CbGpPWpGaD
Phylloquinone—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.00143	0.00278	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—PLAUR—epilepsy syndrome	0.00143	0.006	CbGpPWpGaD
Phylloquinone—Dizziness—Acetazolamide—epilepsy syndrome	0.00141	0.00275	CcSEcCtD
Phylloquinone—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00141	0.00275	CcSEcCtD
Phylloquinone—Sweating increased—Topiramate—epilepsy syndrome	0.00141	0.00275	CcSEcCtD
Phylloquinone—Flushing—Pregabalin—epilepsy syndrome	0.00139	0.00272	CcSEcCtD
Phylloquinone—Pain—Clonazepam—epilepsy syndrome	0.00139	0.0027	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	0.00138	0.0058	CbGpPWpGaD
Phylloquinone—Dyspnoea—Carbamazepine—epilepsy syndrome	0.00137	0.00267	CcSEcCtD
Phylloquinone—Pain—Oxcarbazepine—epilepsy syndrome	0.00137	0.00267	CcSEcCtD
Phylloquinone—Immune system disorder—Pregabalin—epilepsy syndrome	0.00136	0.00265	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.00135	0.0057	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.00133	0.00259	CcSEcCtD
Phylloquinone—Dyspnoea—Lamotrigine—epilepsy syndrome	0.00132	0.00258	CcSEcCtD
Phylloquinone—Pain—Carbamazepine—epilepsy syndrome	0.00131	0.00256	CcSEcCtD
Phylloquinone—Dizziness—Propofol—epilepsy syndrome	0.00131	0.00256	CcSEcCtD
Phylloquinone—Hypersensitivity—Diazepam—epilepsy syndrome	0.00131	0.00255	CcSEcCtD
Phylloquinone—Dizziness—Midazolam—epilepsy syndrome	0.00128	0.0025	CcSEcCtD
Phylloquinone—Pain—Lamotrigine—epilepsy syndrome	0.00127	0.00248	CcSEcCtD
Phylloquinone—Dizziness—Levetiracetam—epilepsy syndrome	0.00127	0.00247	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—AKT1—epilepsy syndrome	0.00126	0.00532	CbGpPWpGaD
Phylloquinone—Immune system disorder—Gabapentin—epilepsy syndrome	0.00124	0.00243	CcSEcCtD
Phylloquinone—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00124	0.00242	CcSEcCtD
Phylloquinone—Dizziness—Fosphenytoin—epilepsy syndrome	0.00122	0.00239	CcSEcCtD
Phylloquinone—Erythema—Gabapentin—epilepsy syndrome	0.0012	0.00234	CcSEcCtD
Phylloquinone—Hypersensitivity—Clonazepam—epilepsy syndrome	0.00119	0.00233	CcSEcCtD
Phylloquinone—Dizziness—Vigabatrin—epilepsy syndrome	0.00119	0.00233	CcSEcCtD
Phylloquinone—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00119	0.00231	CcSEcCtD
Phylloquinone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.00118	0.0023	CcSEcCtD
Phylloquinone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00118	0.0023	CcSEcCtD
Phylloquinone—Dizziness—Diazepam—epilepsy syndrome	0.00117	0.00229	CcSEcCtD
Phylloquinone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.00114	0.00223	CcSEcCtD
Phylloquinone—Dizziness—Felbamate—epilepsy syndrome	0.00114	0.00222	CcSEcCtD
Phylloquinone—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.00113	0.00221	CcSEcCtD
Phylloquinone—Dizziness—Zonisamide—epilepsy syndrome	0.00111	0.00217	CcSEcCtD
Phylloquinone—Hypotension—Valproic Acid—epilepsy syndrome	0.0011	0.00215	CcSEcCtD
Phylloquinone—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.00109	0.00213	CcSEcCtD
Phylloquinone—Flushing—Topiramate—epilepsy syndrome	0.00108	0.0021	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—AKT1—epilepsy syndrome	0.00107	0.00451	CbGpPWpGaD
Phylloquinone—Dizziness—Clonazepam—epilepsy syndrome	0.00107	0.00209	CcSEcCtD
Phylloquinone—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.00107	0.00208	CcSEcCtD
Phylloquinone—Dizziness—Phenytoin—epilepsy syndrome	0.00107	0.00208	CcSEcCtD
Phylloquinone—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00106	0.00207	CcSEcCtD
Phylloquinone—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00105	0.00205	CcSEcCtD
Phylloquinone—Immune system disorder—Topiramate—epilepsy syndrome	0.00105	0.00204	CcSEcCtD
Phylloquinone—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.00103	0.00201	CcSEcCtD
Phylloquinone—Dizziness—Carbamazepine—epilepsy syndrome	0.00102	0.00198	CcSEcCtD
Phylloquinone—Pain—Valproic Acid—epilepsy syndrome	0.00101	0.00197	CcSEcCtD
Phylloquinone—Erythema—Topiramate—epilepsy syndrome	0.00101	0.00197	CcSEcCtD
Phylloquinone—Hypotension—Pregabalin—epilepsy syndrome	0.000997	0.00194	CcSEcCtD
Phylloquinone—Dizziness—Lamotrigine—epilepsy syndrome	0.000983	0.00192	CcSEcCtD
Phylloquinone—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000979	0.00191	CcSEcCtD
Phylloquinone—Dyspnoea—Pregabalin—epilepsy syndrome	0.000952	0.00186	CcSEcCtD
Phylloquinone—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000946	0.00184	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—EIF2S1—epilepsy syndrome	0.000915	0.00385	CbGpPWpGaD
Phylloquinone—Hypotension—Gabapentin—epilepsy syndrome	0.000915	0.00178	CcSEcCtD
Phylloquinone—Pain—Pregabalin—epilepsy syndrome	0.000913	0.00178	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ACTB—epilepsy syndrome	0.000904	0.0038	CbGpPWpGaD
Phylloquinone—Dyspnoea—Gabapentin—epilepsy syndrome	0.000873	0.0017	CcSEcCtD
Phylloquinone—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00087	0.0017	CcSEcCtD
Phylloquinone—Pain—Gabapentin—epilepsy syndrome	0.000837	0.00163	CcSEcCtD
Phylloquinone—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000796	0.00155	CcSEcCtD
Phylloquinone—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000786	0.00153	CcSEcCtD
Phylloquinone—Dizziness—Valproic Acid—epilepsy syndrome	0.000781	0.00152	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—BCHE—epilepsy syndrome	0.000778	0.00327	CbGpPWpGaD
Phylloquinone—Hypotension—Topiramate—epilepsy syndrome	0.00077	0.0015	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	0.000768	0.00323	CbGpPWpGaD
Phylloquinone—Dyspnoea—Topiramate—epilepsy syndrome	0.000734	0.00143	CcSEcCtD
Phylloquinone—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000721	0.00141	CcSEcCtD
Phylloquinone—Dizziness—Pregabalin—epilepsy syndrome	0.000706	0.00138	CcSEcCtD
Phylloquinone—Pain—Topiramate—epilepsy syndrome	0.000704	0.00137	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—PLAUR—epilepsy syndrome	0.000677	0.00285	CbGpPWpGaD
Phylloquinone—Dizziness—Gabapentin—epilepsy syndrome	0.000647	0.00126	CcSEcCtD
Phylloquinone—Hypersensitivity—Topiramate—epilepsy syndrome	0.000607	0.00118	CcSEcCtD
Phylloquinone—Dizziness—Topiramate—epilepsy syndrome	0.000545	0.00106	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—AGT—epilepsy syndrome	0.000478	0.00201	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—POMC—epilepsy syndrome	0.000402	0.00169	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—CCL2—epilepsy syndrome	0.000393	0.00165	CbGpPWpGaD
